Novo Nordisk A/S
TABLET FORMULATION COMPRISING A GLP-1 PEPTIDE AND A DELIVERY AGENT
Last updated:
Abstract:
The present invention relates to solid compositions comprising a GLP-1 peptide and a delivery agent, such as SNAC, as well as uses thereof.
Status:
Application
Type:
Utility
Filling date:
14 May 2021
Issue date:
9 Sep 2021